Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gregory

Showing results (831-840 of 930) with videos related to

Pageof 93
Sort By:
Blood|October 25, 2011
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysisGareth J Morgan, Walter M Gregory, Faith E Davies, et al.
Lancet (London, England)|December 7, 2010
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Blood|May 22, 2020
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trialsCharlotte A Bradbury, Zoe Craig, Gordon Cook, et al.
Journal of Clinical Medicine|June 26, 2026
Resolution of Pneumomediastinum, Cervicofacial Emphysema, and Internal Ophthalmoplegia with Hyperbaric Oxygen Therapy After Hip Arthroscopy: A Case ReportSamuel J Thomas, Jeffery M Bao, Aida Ansari, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 19, 2022
Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosisMatthew R Markovetz, Ian C Garbarine, Cameron B Morrison, et al.
Blood|November 28, 2014
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocationsCharlotte Pawlyn, Lorenzo Melchor, Alex Murison, et al.
Injury|September 1, 2016
Terrorist attacks in Paris: Surgical trauma experience in a referral centerThomas M Gregory, Thomas Bihel, Pierre Guigui, et al.
Haematologica|November 8, 2011
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial resultsGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Blood|July 10, 2010
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBrian A Walker, Paola E Leone, Laura Chiecchio, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
Pageof 93

Showing results (831-840 of 930) with videos related to

Sort By:
Pageof 93
Blood|October 25, 2011
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysisGareth J Morgan, Walter M Gregory, Faith E Davies, et al.
Lancet (London, England)|December 7, 2010
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Blood|May 22, 2020
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trialsCharlotte A Bradbury, Zoe Craig, Gordon Cook, et al.
Journal of Clinical Medicine|June 26, 2026
Resolution of Pneumomediastinum, Cervicofacial Emphysema, and Internal Ophthalmoplegia with Hyperbaric Oxygen Therapy After Hip Arthroscopy: A Case ReportSamuel J Thomas, Jeffery M Bao, Aida Ansari, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 19, 2022
Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosisMatthew R Markovetz, Ian C Garbarine, Cameron B Morrison, et al.
Blood|November 28, 2014
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocationsCharlotte Pawlyn, Lorenzo Melchor, Alex Murison, et al.
Injury|September 1, 2016
Terrorist attacks in Paris: Surgical trauma experience in a referral centerThomas M Gregory, Thomas Bihel, Pierre Guigui, et al.
Haematologica|November 8, 2011
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial resultsGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Blood|July 10, 2010
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic valueBrian A Walker, Paola E Leone, Laura Chiecchio, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
Pageof 93